Member Info for nissangtr786

Https://zakstraderscafe.com/bulletin-board-heroes-june-16/7184/

9:47 in.

40p incoming imo.

@starresnstoff I would love it if Budd releases a £10M+ contract RNS. Could happen easily anyday now with the NHS and it surges to over 50p.

To be honest a lot of big sells as well.

Also markets love when money is coming in and this news is exactly what help get more money in the long-term. Win win for investors todays RNS. Anyway today’s news makes me relaxed holding this.

Avacta hit 180p+ on nothing from like 41p. Todays news is way bigger than anything Avacta have released in there history.

Todays news at least makes it a great longer-term hold now. Massively derisked which new investors will like.

I hope my dream 123p happens very soon but even back to high 40’s would be great.

Great news. It seemed from researching this was gonna happen. I remember the trolls saying they won’t get anything recently. Genedrive now gone into the big leagues.

Maybe some leak from inside. I would love an intraday RNS and a surge back into the 30’s/40’s. Surprised this went back down so low after funding was secured.

They can sell now in a meaningful way. Genedrive should rocket soon to 35p imo.

I remember the 150p days.

Looks like I will have to hold in long term and hope for another pump to 40’s.

My prediction was based on what happened 2 years ago and more takeup by the NHS as Genedrive usually surges but it now seems to be no longer a stock that does that. I will now change my prediction to 37.5p by end of the month.

Https://www.nice.org.uk/guidance/indevelopment/gid-dg10054/consultation/html-content

This was updated yesterday.

Crooty: bankruptstock is trolling and is a huge deramper. It would be NICE if hit the 30's tomorrow.

Probably peak at 26p and go back to 17p.

Https://research.manchester.ac.uk/en/persons/william.newman

b) Pharmacogenetics

I am interested in how patients respond to their medication.

I work closely with John McDermott (Genomic Medicine), Katherine Payne, Stuart Wright, Alex Thompson (Health Economics), Paul Wilson (Implementation Science), Mike Turner, Lu Shin Wong (Chemistry), Antony Adamson (Genomics) and Videha Sharma (Health Informatics) on clinical implementation of pharmacogenetics and how novel rapid genetic tests can improve outcomes.

I undertook an NIHR i4i grant (PALOH) working with colleagues in neonatal units in Liverpool and Manchester and Genedrive to use point of care genetic testing to avoid hearing loss in babies exposed to the antibiotic gentamicin. This work resulted in a NICE Early Value Assessment before national adoption and was awarded the New Statesman Healthcare Positive Impact Award 2022.

Our recent studies in primary care (PROGRESS) and on rapid diagnostics (DEVOTE) have been funded by NHSE and Innovate UK, respectively.

Well it did three years ago so you could be right. I know you are trolling but still it could happen. :)

I have a feeling this could fly to 75p this month. GLA!